Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 921 entries
Sorted by: Best Match Show Resources per page
RESPONSE: Re: Folylpolyglutamyl Synthetase Gene Transfer and Glioma Antifolate Sensitivity in Culture and In Vivo.

Journal of the National Cancer Institute

Aghi M, Kramm CM, Breakefield XO.
PMID: 10580034
J Natl Cancer Inst. 1999 Dec 01;91(23):2048-2049. doi: 10.1093/jnci/91.23.2048.

No abstract available.

Cite
Aghi M, Kramm CM, Breakefield XO. RESPONSE: Re: Folylpolyglutamyl Synthetase Gene Transfer and Glioma Antifolate Sensitivity in Culture and In Vivo. J Natl Cancer Inst. 1999;91(23):2048-2049doi: 10.1093/jnci/91.23.2048.
Aghi, M., Kramm, C. M., & Breakefield, X. O. (1999). RESPONSE: Re: Folylpolyglutamyl Synthetase Gene Transfer and Glioma Antifolate Sensitivity in Culture and In Vivo. Journal of the National Cancer Institute, 91(23), 2048-2049. https://doi.org/10.1093/jnci/91.23.2048
Aghi, et al. "RESPONSE: Re: Folylpolyglutamyl Synthetase Gene Transfer and Glioma Antifolate Sensitivity in Culture and In Vivo." Journal of the National Cancer Institute vol. 91,23 (1999): 2048-2049. doi: https://doi.org/10.1093/jnci/91.23.2048
Aghi M, Kramm CM, Breakefield XO. RESPONSE: Re: Folylpolyglutamyl Synthetase Gene Transfer and Glioma Antifolate Sensitivity in Culture and In Vivo. J Natl Cancer Inst. 1999 Dec 01;91(23):2048-2049. doi: 10.1093/jnci/91.23.2048. PMID: 10580034.
Copy Download .nbib Format: NLM
RESPONSE: re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 .

Journal of the National Cancer Institute

Amirimani B, Walker AH, Weber BL, Rebbeck TR.
PMID: 10491443
J Natl Cancer Inst. 1999 Sep 15;91(18):1588-90. doi: 10.1093/jnci/91.18.1588.

No abstract available.

Cite
Amirimani B, Walker AH, Weber BL, et al. RESPONSE: re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 . J Natl Cancer Inst. 1999;91(18):1588-90doi: 10.1093/jnci/91.18.1588.
Amirimani, B., Walker, A. H., Weber, B. L., & Rebbeck, T. R. (1999). RESPONSE: re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 . Journal of the National Cancer Institute, 91(18), 1588-90. https://doi.org/10.1093/jnci/91.18.1588
Amirimani, et al. "RESPONSE: re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 ." Journal of the National Cancer Institute vol. 91,18 (1999): 1588-90. doi: https://doi.org/10.1093/jnci/91.18.1588
Amirimani B, Walker AH, Weber BL, Rebbeck TR. RESPONSE: re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4 . J Natl Cancer Inst. 1999 Sep 15;91(18):1588-90. doi: 10.1093/jnci/91.18.1588. PMID: 10491443.
Copy Download .nbib Format: NLM
RESPONSE: re: preclinical and clinical development of cyclin-dependent kinase modulators.

Journal of the National Cancer Institute

Senderowicz AM, Sausville EA.
PMID: 10904097
J Natl Cancer Inst. 2000 Jul 19;92(14):1185. doi: 10.1093/jnci/92.14.1185.

No abstract available.

Cite
Senderowicz AM, Sausville EA. RESPONSE: re: preclinical and clinical development of cyclin-dependent kinase modulators. J Natl Cancer Inst. 2000;92(14):1185doi: 10.1093/jnci/92.14.1185.
Senderowicz, A. M., & Sausville, E. A. (2000). RESPONSE: re: preclinical and clinical development of cyclin-dependent kinase modulators. Journal of the National Cancer Institute, 92(14), 1185. https://doi.org/10.1093/jnci/92.14.1185
Senderowicz, and Sausville. "RESPONSE: re: preclinical and clinical development of cyclin-dependent kinase modulators." Journal of the National Cancer Institute vol. 92,14 (2000): 1185. doi: https://doi.org/10.1093/jnci/92.14.1185
Senderowicz AM, Sausville EA. RESPONSE: re: preclinical and clinical development of cyclin-dependent kinase modulators. J Natl Cancer Inst. 2000 Jul 19;92(14):1185. doi: 10.1093/jnci/92.14.1185. PMID: 10904097.
Copy Download .nbib Format: NLM
Foundation celebrates 20th anniversary.

Journal of the National Cancer Institute

[No authors listed]
PMID: 10974073
J Natl Cancer Inst. 2000 Sep 06;92(17):1380. doi: 10.1093/jnci/92.17.1380.

No abstract available.

Cite
Foundation celebrates 20th anniversary. J Natl Cancer Inst. 2000;92(17):1380doi: 10.1093/jnci/92.17.1380.
(2000). Foundation celebrates 20th anniversary. Journal of the National Cancer Institute, 92(17), 1380. https://doi.org/10.1093/jnci/92.17.1380
"Foundation celebrates 20th anniversary." Journal of the National Cancer Institute vol. 92,17 (2000): 1380. doi: https://doi.org/10.1093/jnci/92.17.1380
Foundation celebrates 20th anniversary. J Natl Cancer Inst. 2000 Sep 06;92(17):1380. doi: 10.1093/jnci/92.17.1380. PMID: 10974073.
Copy Download .nbib Format: NLM
RESPONSE: patient costs on clinical trials.

Journal of the National Cancer Institute

Wagner JC, Alberts SR.
PMID: 10974085
J Natl Cancer Inst. 2000 Sep 06;92(17):1442-3. doi: 10.1093/jnci/92.17.1442.

No abstract available.

Cite
Wagner JC, Alberts SR. RESPONSE: patient costs on clinical trials. J Natl Cancer Inst. 2000;92(17):1442-3doi: 10.1093/jnci/92.17.1442.
Wagner, J. C., & Alberts, S. R. (2000). RESPONSE: patient costs on clinical trials. Journal of the National Cancer Institute, 92(17), 1442-3. https://doi.org/10.1093/jnci/92.17.1442
Wagner, and Alberts. "RESPONSE: patient costs on clinical trials." Journal of the National Cancer Institute vol. 92,17 (2000): 1442-3. doi: https://doi.org/10.1093/jnci/92.17.1442
Wagner JC, Alberts SR. RESPONSE: patient costs on clinical trials. J Natl Cancer Inst. 2000 Sep 06;92(17):1442-3. doi: 10.1093/jnci/92.17.1442. PMID: 10974085.
Copy Download .nbib Format: NLM
The feisty Woman's breast cancer book.

Journal of the National Cancer Institute

Thompson MO.
PMID: 10841831
J Natl Cancer Inst. 2000 Jun 07;92(11):940-1. doi: 10.1093/jnci/92.11.940.

No abstract available.

Cite
Thompson MO. The feisty Woman's breast cancer book. J Natl Cancer Inst. 2000;92(11):940-1doi: 10.1093/jnci/92.11.940.
Thompson, M. O. (2000). The feisty Woman's breast cancer book. Journal of the National Cancer Institute, 92(11), 940-1. https://doi.org/10.1093/jnci/92.11.940
Thompson. "The feisty Woman's breast cancer book." Journal of the National Cancer Institute vol. 92,11 (2000): 940-1. doi: https://doi.org/10.1093/jnci/92.11.940
Thompson MO. The feisty Woman's breast cancer book. J Natl Cancer Inst. 2000 Jun 07;92(11):940-1. doi: 10.1093/jnci/92.11.940. PMID: 10841831.
Copy Download .nbib Format: NLM
RESPONSE: Let's leave the date out of the name of the standard population.

Journal of the National Cancer Institute

Anderson RN, Freedman MA, Rosenberg HM, Sondik EJ.
PMID: 10922416
J Natl Cancer Inst. 2000 Aug 02;92(15):1270. doi: 10.1093/jnci/92.15.1270.

No abstract available.

Cite
Anderson RN, Freedman MA, Rosenberg HM, et al. RESPONSE: Let's leave the date out of the name of the standard population. J Natl Cancer Inst. 2000;92(15):1270doi: 10.1093/jnci/92.15.1270.
Anderson, R. N., Freedman, M. A., Rosenberg, H. M., & Sondik, E. J. (2000). RESPONSE: Let's leave the date out of the name of the standard population. Journal of the National Cancer Institute, 92(15), 1270. https://doi.org/10.1093/jnci/92.15.1270
Anderson, et al. "RESPONSE: Let's leave the date out of the name of the standard population." Journal of the National Cancer Institute vol. 92,15 (2000): 1270. doi: https://doi.org/10.1093/jnci/92.15.1270
Anderson RN, Freedman MA, Rosenberg HM, Sondik EJ. RESPONSE: Let's leave the date out of the name of the standard population. J Natl Cancer Inst. 2000 Aug 02;92(15):1270. doi: 10.1093/jnci/92.15.1270. PMID: 10922416.
Copy Download .nbib Format: NLM
EDITOR'S NOTE: re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.

Journal of the National Cancer Institute

[No authors listed]
PMID: 10922418
J Natl Cancer Inst. 2000 Aug 02;92(15):1272-3. doi: 10.1093/jnci/92.15.1272.

No abstract available.

Cite
EDITOR'S NOTE: re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma. J Natl Cancer Inst. 2000;92(15):1272-3doi: 10.1093/jnci/92.15.1272.
(2000). EDITOR'S NOTE: re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma. Journal of the National Cancer Institute, 92(15), 1272-3. https://doi.org/10.1093/jnci/92.15.1272
"EDITOR'S NOTE: re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma." Journal of the National Cancer Institute vol. 92,15 (2000): 1272-3. doi: https://doi.org/10.1093/jnci/92.15.1272
EDITOR'S NOTE: re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma. J Natl Cancer Inst. 2000 Aug 02;92(15):1272-3. doi: 10.1093/jnci/92.15.1272. PMID: 10922418.
Copy Download .nbib Format: NLM
RESPONSE: re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.

Journal of the National Cancer Institute

Hortobagyi GN, Buzdar AU.
PMID: 10922419
J Natl Cancer Inst. 2000 Aug 02;92(15):1273. doi: 10.1093/jnci/92.15.1273.

No abstract available.

Cite
Hortobagyi GN, Buzdar AU. RESPONSE: re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma. J Natl Cancer Inst. 2000;92(15):1273doi: 10.1093/jnci/92.15.1273.
Hortobagyi, G. N., & Buzdar, A. U. (2000). RESPONSE: re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma. Journal of the National Cancer Institute, 92(15), 1273. https://doi.org/10.1093/jnci/92.15.1273
Hortobagyi, and Buzdar. "RESPONSE: re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma." Journal of the National Cancer Institute vol. 92,15 (2000): 1273. doi: https://doi.org/10.1093/jnci/92.15.1273
Hortobagyi GN, Buzdar AU. RESPONSE: re: randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma. J Natl Cancer Inst. 2000 Aug 02;92(15):1273. doi: 10.1093/jnci/92.15.1273. PMID: 10922419.
Copy Download .nbib Format: NLM
EGON LORENZ, 1892-1954.

Journal of the National Cancer Institute

[No authors listed]
PMID: 13233930
J Natl Cancer Inst. 1955 Feb;15(4):iii-xi.

No abstract available.

Cite
EGON LORENZ, 1892-1954. J Natl Cancer Inst. 1955;15(4):iii-xi
(1955). EGON LORENZ, 1892-1954. Journal of the National Cancer Institute, 15(4), iii-xi.
"EGON LORENZ, 1892-1954." Journal of the National Cancer Institute vol. 15,4 (1955): iii-xi.
EGON LORENZ, 1892-1954. J Natl Cancer Inst. 1955 Feb;15(4):iii-xi. PMID: 13233930.
Copy Download .nbib Format: NLM
Eliminating publication bias: the effect of negative trial results.

Journal of the National Cancer Institute

Reynolds T.
PMID: 10793099
J Natl Cancer Inst. 2000 May 03;92(9):682. doi: 10.1093/jnci/92.9.682.

No abstract available.

Cite
Reynolds T. Eliminating publication bias: the effect of negative trial results. J Natl Cancer Inst. 2000;92(9):682doi: 10.1093/jnci/92.9.682.
Reynolds, T. (2000). Eliminating publication bias: the effect of negative trial results. Journal of the National Cancer Institute, 92(9), 682. https://doi.org/10.1093/jnci/92.9.682
Reynolds, T. "Eliminating publication bias: the effect of negative trial results." Journal of the National Cancer Institute vol. 92,9 (2000): 682. doi: https://doi.org/10.1093/jnci/92.9.682
Reynolds T. Eliminating publication bias: the effect of negative trial results. J Natl Cancer Inst. 2000 May 03;92(9):682. doi: 10.1093/jnci/92.9.682. PMID: 10793099.
Copy Download .nbib Format: NLM
MEMORANDUM FOR: science writers and editors on the journal press list : genetic similarity found between ductal carcinomas In situ and their recurrences.

Journal of the National Cancer Institute

Arnold K, Eckstein D.
PMID: 10675366
J Natl Cancer Inst. 2000 Feb 16;92(4):287A-A. doi: 10.1093/jnci/92.4.287a.

No abstract available.

Cite
Arnold K, Eckstein D. MEMORANDUM FOR: science writers and editors on the journal press list : genetic similarity found between ductal carcinomas In situ and their recurrences. J Natl Cancer Inst. 2000;92(4):287A-Adoi: 10.1093/jnci/92.4.287a.
Arnold, K., & Eckstein, D. (2000). MEMORANDUM FOR: science writers and editors on the journal press list : genetic similarity found between ductal carcinomas In situ and their recurrences. Journal of the National Cancer Institute, 92(4), 287A-A. https://doi.org/10.1093/jnci/92.4.287a
Arnold, and Eckstein. "MEMORANDUM FOR: science writers and editors on the journal press list : genetic similarity found between ductal carcinomas In situ and their recurrences." Journal of the National Cancer Institute vol. 92,4 (2000): 287A-A. doi: https://doi.org/10.1093/jnci/92.4.287a
Arnold K, Eckstein D. MEMORANDUM FOR: science writers and editors on the journal press list : genetic similarity found between ductal carcinomas In situ and their recurrences. J Natl Cancer Inst. 2000 Feb 16;92(4):287A-A. doi: 10.1093/jnci/92.4.287a. PMID: 10675366.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 921 entries